Advertisement
Advertisement

TTRX

TTRX logo

Turn Therapeutics Inc. Common Stock

10.41
USD
Sponsored
+0.80
+8.32%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

10.39

-0.02
-0.23%

Turn Therapeutics Inc. Common Stock Profile

About

Turn Therapeutics is a clinical-stage biotechnology company developing next-generation dermatology, wound and anti-infective therapies. Turn Therapeutics is based in WESTLAKE VILLAGE, Calif.

Info & Links

CEO

Bradley Burnam

Headquarters

250 NORTH WESTLAKE BLVD., #210
WESTLAKE VILLAGE, CA 91362, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.turntherapeutics.com

Auditor

WithumSmith+Brown, PC

Share holders

677

Employees

2

Turn Therapeutics Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

309.38M

Enterprise Value

304.10M

Enterprise Value/EBITDA(ttm)

-114.00

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

50.69

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-385.86%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-2.67M

Net Income Available to Common(ttm)

-2.88M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

--

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

29.79M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

11.22M

Total Cash Per Share(mrq)

0.38

Total Debt(mrq)

5.94M

Total Debt/Equity(mrq)

97.04%

Current Ratio(mrq)

2.23%

Quick Ratio(mrq)

2.23%

Book Value Per Share(mrq)

0.21

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.06

Free Cash Flow(ytd)

-1.63M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement